Psoriasis News and Research

Latest Psoriasis News and Research

Anacor, Medicis collaborate to discover and develop boron-based treatment for acne

Anacor, Medicis collaborate to discover and develop boron-based treatment for acne

Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey

Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey

Circassia acquires global rights to novel topical therapeutic for psoriasis and atopic dermatitis

Circassia acquires global rights to novel topical therapeutic for psoriasis and atopic dermatitis

NMS Labs launches unique test for Methotrexate

NMS Labs launches unique test for Methotrexate

Researchers identify immune cell population that acts as body's border patrol with the outside world

Researchers identify immune cell population that acts as body's border patrol with the outside world

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

Anacor initiates dosing in AN2728 Phase 2b trial for psoriasis

Anacor initiates dosing in AN2728 Phase 2b trial for psoriasis

Isotechnika closes licensing deal with ILJIN Life Science to advance development of voclosporin

Isotechnika closes licensing deal with ILJIN Life Science to advance development of voclosporin

VBL commences two studies to evaluate efficacy, safety of VB-111 in advanced cancers

VBL commences two studies to evaluate efficacy, safety of VB-111 in advanced cancers

BGU, PTT sign R&D collaboration agreement for commercial development of green algae strain

BGU, PTT sign R&D collaboration agreement for commercial development of green algae strain

Prototype drug halts GVHD in mouse models of bone marrow transplantation

Prototype drug halts GVHD in mouse models of bone marrow transplantation

Provectus announces completion of PV-10 Phase 1 trial in patients with liver cancer

Provectus announces completion of PV-10 Phase 1 trial in patients with liver cancer

DMP1 protein prevents endothelial cells to respond to VEGF

DMP1 protein prevents endothelial cells to respond to VEGF

AB Science initiates recruitment in masitinib phase 3 study in severe persistent asthma

AB Science initiates recruitment in masitinib phase 3 study in severe persistent asthma

ChemoCentryx commences CCX832 Phase I trial in patients with psoriasis

ChemoCentryx commences CCX832 Phase I trial in patients with psoriasis

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Boehringer Ingelheim to acquire Amgen's Fremont California development and manufacturing facility

Boehringer Ingelheim to acquire Amgen's Fremont California development and manufacturing facility

Manhattan enters settlement and release agreement with Nordic and H Pharmaceuticals

Manhattan enters settlement and release agreement with Nordic and H Pharmaceuticals

KYTHERA and Intendis initiate ATX-101 European Phase III studies for reduction of submental fat

KYTHERA and Intendis initiate ATX-101 European Phase III studies for reduction of submental fat

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.